Kevan R. Thompson
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kevan R. Thompson.
Synthetic Communications | 1989
Peter L. Barker; Paul E. Finke; Kevan R. Thompson
Abstract An improved method for the preparation of 2,3-unsubstituted benzofurans is described. Specifically, the PPA catalysed cyclization of aryloxyacetaldehyde acetals to give (4–7)-substituted benzofurans has been achieved.
Bioorganic & Medicinal Chemistry Letters | 1991
William K. Hagmann; Shrenik K. Shah; Conrad P. Dorn; Laura A. O'Grady; Jeffrey J. Hale; Pau.E. Finke; Kevan R. Thompson; Brause Ka; Bonnie M. Ash; Hazel Weston; M.Ellen Dahlgren; Alan L. Maycock; Pam S. Dellea; Karen M. Hand; Donald G. Osinga; Robert J. Bonney; Philip Davies; Daniel S. Fletcher; James B. Doherty
Abstract Simple 3-alkyl-4-azetidinones have been previously reported as potent inhibitors of human leukocyte elastase (HLE). Further modification of these simple monocyclic β-lactams has led to development of substituted 4-azetidinones that both inhibit HLE in a time dependent manner and, like previously reported modified cephalosporin sulfones, prevent HLE-induced lung damage in hamsters.
Bioorganic & Medicinal Chemistry Letters | 1993
Kevan R. Thompson; Paul E. Finke; Shrenik K. Shah; Bonnie M. Ashe; Mary Ellen Dahlgren; Alan L. Maycock; James B. Doherty
Abstract Penicillin amides substituted at C-6 with either an α- or β-trifluoroacetamido or an α-alkoxy functionality are reported as human leukocyte elastase (HLE) inhibitors. The structure activity relations for these derivatives are discussed and compared to the corresponding known cephalosporin structures in terms of chemical stability, HLE inhibition, and efficacy in an intratracheal (IT) lung hemorrhage assay.
Bioorganic & Medicinal Chemistry Letters | 1992
William K. Hagmann; Kevan R. Thompson; Shrenik K. Shah; Paul E. Finke; Bonnie M. Ashe; Hazel Weston; Alan L. Maycock; James B. Doherty
Abstract Substituted monocyclic β-lactam have recently been reported as inhibitors of human leukocyte elastase (HLE). Simple N-acetyl-2-azetidinone lead structures were found to undergo N-deacylation as well as β-lactam ring opening. The development of the N-carbamoyl-2-azetidinone nucleus was crucial to the stability of these compounds for effective oral bioavailability.
Nature | 1986
James B. Doherty; Bonnie M. Ashe; Lawrence W. Argenbright; Peter L. Barker; Robert J. Bonney; Chandler Go; Mary Ellen Dahlgren; Conrad P. Dorn; Paul E. Finke; Raymond A. Firestone; Daniel A. Fletcher; William K. Hagmann; Richard A. Mumford; Laura A. O'Grady; Alan L. Maycock; Judith M. Pisano; Shrenik K. Shah; Kevan R. Thompson; Morris Zimmerman
Archive | 1983
James B. Doherty; Bonnie M. Ashe; Paul E. Finke; Shrenik K. Shah; Kevan R. Thompson; Morris Zimmerman
Journal of Medicinal Chemistry | 1990
Paul E. Finke; Bonnie M. Ashe; Wilson B. Knight; Alan L. Maycock; Navia Ma; Shrenik K. Shah; Kevan R. Thompson; Dennis J. Underwood; Hazel Weston; Morris Zimmerman
Archive | 1986
James B. Doherty; Paul E. Finke; Raymond A. Firestone; William K. Hagmann; Shrenik K. Shah; Kevan R. Thompson
Archive | 1985
Kevan R. Thompson; Paul E. Finke; James B. Doherty
Archive | 1984
James B. Doherty; Paul E. Finke; Raymond A. Firestone; William K. Hagmann; Shrenik K. Shah; Kevan R. Thompson